Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 3
1986 11
1987 26
1988 17
1989 54
1990 34
1991 40
1992 39
1993 49
1994 40
1995 45
1996 38
1997 40
1998 45
1999 53
2000 35
2001 28
2002 33
2003 41
2004 40
2005 34
2006 38
2007 26
2008 34
2009 32
2010 26
2011 32
2012 39
2013 40
2014 22
2015 23
2016 30
2017 36
2018 45
2019 35
2020 30
2021 30
2022 31
2023 27
2024 33
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,286 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial.
Dunne MW, Aronin SI, Das AF, Akinapelli K, Zelasky MT, Puttagunta S, Boucher HW. Dunne MW, et al. Clin Infect Dis. 2023 Jan 6;76(1):66-77. doi: 10.1093/cid/ciac738. Clin Infect Dis. 2023. PMID: 36069202 Free PMC article. Clinical Trial.
In patients with ciprofloxacin-nonsusceptible baseline pathogens, sulopenem was compared for superiority over ciprofloxacin; in patients with ciprofloxacin-susceptible pathogens, the agents were compared for noninferiority. ...CONCLUSIONS: Sulopenem was nonin …
In patients with ciprofloxacin-nonsusceptible baseline pathogens, sulopenem was compared for superiority over ciprofloxacin; i …
Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial.
Ewoldt TMJ, Abdulla A, Rietdijk WJR, Muller AE, de Winter BCM, Hunfeld NGM, Purmer IM, van Vliet P, Wils EJ, Haringman J, Draisma A, Rijpstra TA, Karakus A, Gommers D, Endeman H, Koch BCP. Ewoldt TMJ, et al. Intensive Care Med. 2022 Dec;48(12):1760-1771. doi: 10.1007/s00134-022-06921-9. Epub 2022 Nov 9. Intensive Care Med. 2022. PMID: 36350354 Free PMC article. Clinical Trial.
PURPOSE: Individualising drug dosing using model-informed precision dosing (MIPD) of beta-lactam antibiotics and ciprofloxacin has been proposed as an alternative to standard dosing to optimise antibiotic efficacy in critically ill patients. ...CONCLUSIONS: We could not sh …
PURPOSE: Individualising drug dosing using model-informed precision dosing (MIPD) of beta-lactam antibiotics and ciprofloxacin has be …
Ciprofloxacin versus levofloxacin prophylaxis in hematopoietic stem cell transplantation: A randomized trial.
Farhan S, Mazur I, Hartzell S, Xie P, Neme K, German A, Mikulandric N, Patel K, Wu M, Kortam N, Yaseen A, Sweidan A, Latack K, Emole J, Peres E, Abidi MH, Ramesh M. Farhan S, et al. Int J Infect Dis. 2024 Oct;147:107172. doi: 10.1016/j.ijid.2024.107172. Epub 2024 Jul 15. Int J Infect Dis. 2024. PMID: 39019103 Free article. Clinical Trial.
OBJECTIVES: We aimed to assess whether there is a difference between ciprofloxacin and levofloxacin as prophylaxis in hematopoietic stem cell transplant (SCT) recipients. ...RESULTS: Between June 4, 2018, and May 23, 2022, we randomly assigned 308 consecutive patients to r …
OBJECTIVES: We aimed to assess whether there is a difference between ciprofloxacin and levofloxacin as prophylaxis in hematopoietic s …
Efficacy of inhaled ciprofloxacin agents for the treatment of bronchiectasis: a systematic review and meta-analysis of randomized controlled trials.
Lim JU, Hong SW, Ko JH. Lim JU, et al. Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619875930. doi: 10.1177/1753466619875930. Ther Adv Respir Dis. 2019. PMID: 31538535 Free PMC article.
BACKGROUND: The efficacy of inhaled ciprofloxacin agents in the treatment of patients with bronchiectasis is controversial. The objective of the study was to review systematically the efficacy of inhaled ciprofloxacin agents in patients with bronchiectasis. ...Altho …
BACKGROUND: The efficacy of inhaled ciprofloxacin agents in the treatment of patients with bronchiectasis is controversial. The objec …
Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn's Disease.
Rhodes JM, Subramanian S, Flanagan PK, Horgan GW, Martin K, Mansfield J, Parkes M, Hart A, Dallal H, Iqbal T, Butterworth J, Culshaw K, Probert C. Rhodes JM, et al. Dig Dis Sci. 2021 Aug;66(8):2700-2711. doi: 10.1007/s10620-020-06477-y. Epub 2020 Jul 17. Dig Dis Sci. 2021. PMID: 32681228 Clinical Trial.
METHODS: Adults with moderately active disease (CDAI > 220-450 plus C reactive protein 5 mg/l and/or fecal calprotectin > 250 mug/g) were randomized to receive (open-label) oral budesonide (Entocort CR 9 mg/day 8 weeks, 6 mg/day 2 weeks, 3 mg/day 2 weeks) or oral ciprofl …
METHODS: Adults with moderately active disease (CDAI > 220-450 plus C reactive protein 5 mg/l and/or fecal calprotectin > 250 mug/g) w …
Ciprofloxacin/metronidazole versus beta-lactam-based treatment of intra-abdominal infections: a meta-analysis of comparative trials.
Matthaiou DK, Peppas G, Bliziotis IA, Falagas ME. Matthaiou DK, et al. Int J Antimicrob Agents. 2006 Sep;28(3):159-65. doi: 10.1016/j.ijantimicag.2006.04.005. Epub 2006 Aug 8. Int J Antimicrob Agents. 2006. PMID: 16899353 Review.
Thus, we sought to review the evidence from available comparative clinical trials studying ciprofloxacin/metronidazole versus broad-spectrum beta-lactam-based regimens in the treatment of intra-abdominal infections. ...There was a statistically significant difference betwe …
Thus, we sought to review the evidence from available comparative clinical trials studying ciprofloxacin/metronidazole versus broad-s …
A systematic review and meta-analysis of levofloxacin and ciprofloxacin in the treatment of urinary tract infection.
Xue Z, Xiang Y, Li Y, Yang Q. Xue Z, et al. Ann Palliat Med. 2021 Sep;10(9):9765-9771. doi: 10.21037/apm-21-2042. Ann Palliat Med. 2021. PMID: 34628902 Free article.
BACKGROUND: The efficacy of levofloxacin and ciprofloxacin in the treatment of urinary tract infection is not clear yet. This study perform a meta-analysis to explore the differences between the two against urinary tract infection (UTI). ...All the retrieved literatures we …
BACKGROUND: The efficacy of levofloxacin and ciprofloxacin in the treatment of urinary tract infection is not clear yet. This study p …
Efficacy of empirical Ciprofloxacin or Cefixime plus Metronidazole therapy for the treatment of liver abscess: a randomized control clinical trial.
Priya G L, Dhibar DP, Saroch A, Sharma N, Sharma V, Verma N, Chaluvashetty SB, Prakash A, Kaur H. Priya G L, et al. Sci Rep. 2024 May 20;14(1):11430. doi: 10.1038/s41598-024-59607-1. Sci Rep. 2024. PMID: 38769330 Free PMC article. Clinical Trial.
In this double blind randomized control clinical trial 69 participants received Ciprofloxacin (500 mg q 12 hourly) and 71 participants received Cefixime (200 mg q 12 hourly) orally for 2 weeks. ...Out of 140 participants, 89.3% (N = 125) achieved clinical cure, 59 (85.5%) …
In this double blind randomized control clinical trial 69 participants received Ciprofloxacin (500 mg q 12 hourly) and 71 participant …
On ciprofloxacin concentration in chronic rhinosinusitis.
Gameiro Dos Santos J, Figueirinhas R, Liberal JP, Almeida JC, Sousa J, Falcão A, Vicente C, Paço J, Sousa CA. Gameiro Dos Santos J, et al. Acta Otorrinolaringol Esp (Engl Ed). 2018 Jan-Feb;69(1):35-41. doi: 10.1016/j.otorri.2017.06.008. Epub 2017 Aug 30. Acta Otorrinolaringol Esp (Engl Ed). 2018. PMID: 28859993 Clinical Trial. English, Spanish.
The plasma and mucosal ciprofloxacin concentrations were assayed with high performance liquid chromatography (HPLC) with fluorescence detection (FD). RESULTS: The oral ciprofloxacin achieved better mucosal concentrations but had a significant plasmatic expression in …
The plasma and mucosal ciprofloxacin concentrations were assayed with high performance liquid chromatography (HPLC) with fluorescence …
FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients-efficacy and microbiologic safety.
Moreno AF, Lavín-Alconero L, de Ugarriza PL, Blanco LS, Hernández SC, Burgués JMB, de Miguel MI, Huerta AJG, Zarzuela MP, Boluda B, Humala K, Calabuig ML, Amigo ML, Casas MC, Del Mar García-Saiz M, Verdugo AF, Domínguez JF, Bernal T. Moreno AF, et al. Trials. 2023 Oct 27;24(1):694. doi: 10.1186/s13063-023-07702-5. Trials. 2023. PMID: 37891616 Free PMC article. Clinical Trial.
In the neutropenic phase that occurs after chemotherapy, MRGNB translocation occurs increasing patient's mortality. Fluoroquinolone prophylaxis with ciprofloxacin or levofloxacin efficacy is now being questioned due to the increase of incidence in MRGNB. METHODS: A phase I …
In the neutropenic phase that occurs after chemotherapy, MRGNB translocation occurs increasing patient's mortality. Fluoroquinolone prophyla …
1,286 results

Searches related to "ciprofloxacin"